|
1
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shirabe K, Kanematsu T, Matsumata T,
Adachi E, Akazawa K and Sugimachi K: Factors linked to early
recurrence of small hepatocellular carcinoma after hepatectomy:
Univariate and multivariate analyses. Hepatology. 14:802–805. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamashita Y, Morita K, Iguchi T, Tsujita
E, Soejima Y, Taketomi A and Maehara Y: Surgical impacts of an en
bloc resection of the diaphragm for hepatocellular carcinoma with
gross diaphragmatic involvement. Surg Today. 41:101–106. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sakaguchi T, Suzuki S, Morita Y, Oishi K,
Suzuki A, Fukumoto K, Inaba K, Nakamura S and Konno H: Impact of
the preoperative des-gamma-carboxy prothrombin level on prognosis
after hepatectomy for hepatocellular carcinoma meeting the Milan
criteria. Surg Today. 40:638–645. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Taketomi A, Fukuhara T, Morita K,
Kayashima H, Ninomiya M, Yamashita Y, Ikegami T, Uchiyama H,
Yoshizumi T, Soejima Y, et al: Improved results of a surgical
resection for the recurrence of hepatocellular carcinoma after
living donor liver transplantation. Ann Surg Oncol. 17:2283–2289.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nault JC, De Reyniès A, Villanueva A,
Calderaro J, Rebouissou S, Couchy G, Decaens T, Franco D, Imbeaud
S, Rousseau F, et al: A hepatocellular carcinoma 5-gene score
associated with survival of patients after liver resection.
Gastroenterology. 145:176–187. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Balkwill F and Mantovani A: Inflammation
and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de Visser KE, Eichten A and Coussens LM:
Paradoxical roles of the immune system during cancer development.
Nat Rev Cancer. 6:24–37. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Posner MR: Paradigm shift in the treatment
of head and neck cancer: The role of neoadjuvant chemotherapy.
Oncologist. 10:(Suppl 3). 11–19. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaseb AO, Abaza YM and Roses RE:
Multidisciplinary management of hepatocellular carcinoma. Recent
Results Cancer Res. 190:247–259. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gerber DE: Targeted therapies: A new
generation of cancer treatments. Am Fam Physician. 77:311–319.
2008.PubMed/NCBI
|
|
13
|
Honkanen RE: Cantharidin, another natural
toxin that inhibits the activity of serine/threonine protein
phosphatases types 1 and 2A. FEBS Lett. 330:283–286. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deng LP, Dong J, Cai H and Wang W:
Cantharidin as an antitumor agent: A retrospective review. Curr Med
Chem. 20:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsauer W, Lin JG, Lin PY, Hsu FL and
Chiang HC: The effects of cantharidin analogues on xanthine
oxidase. Anticancer Res. 17:2095–2098. 1997.PubMed/NCBI
|
|
16
|
Lin LH, Huang HS, Lin CC, Lee LW and Lin
PY: Effects of cantharidinimides on human carcinoma cells. Chem
Pharm Bull (Tokyo). 52:855–857. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yeh CB, Su CJ, Hwang JM and Chou MC:
Therapeutic effects of cantharidin analogues without bridging ether
oxygen on human hepatocellular carcinoma cells. Eur J Med Chem.
45:3981–3985. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ravikumar B, Sarkar S, Davies JE, Futter
M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M,
Korolchuk VI, Lichtenberg M, Luo S, et al: Regulation of mammalian
autophagy in physiology and pathophysiology. Physiol Rev.
90:1383–1435. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gual P, Gilgenkrantz H and Lotersztajn S:
Autophagy in chronic liver diseases: The two faces of Janus. Am J
Physiol Cell Physiol. 312:C263–C273. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim KY, Jang HJ, Yang YR, Park KI, Seo J,
Shin IW, Jeon TI, Ahn SC, Suh PG, Osborne TF, et al: Corrigendum:
SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease
through activation of autophagy. Sci Rep. 6:377942016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ogier-Denis E and Codogno P: Autophagy: A
barrier or an adaptive response to cancer. Biochim Biophys Acta.
1603:113–128. 2003.PubMed/NCBI
|
|
22
|
Shintani T and Klionsky DJ: Autophagy in
health and disease: A double-edged sword. Science. 306:990–995.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mariño G and López-Otín C: Autophagy:
Molecular mechanisms, physiological functions and relevance in
human pathology. Cell Mol Life Sci. 61:1439–1454. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eskelinen EL: Maturation of autophagic
vacuoles in mammalian cells. Autophagy. 1:1–10. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guan J, Lo M, Dockery P, Mahon S, Karp CM,
Buckley AR, Lam S, Gout PW and Wang YZ: The xc-cystine/glutamate
antiporter as a potential therapeutic target for small-cell lung
cancer: Use of sulfasalazine. Cancer Chemother Pharmacol.
64:463–472. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo W, Zhao Y, Zhang Z, Tan N, Zhao F, Ge
C, Liang L, Jia D, Chen T, Yao M, et al: Disruption of xCT inhibits
cell growth via the ROS/autophagy pathway in hepatocellular
carcinoma. Cancer Lett. 312:55–61. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bruix J, Reig M and Sherman M:
Evidence-based diagnosis, staging, and treatment of patients with
hepatocellular carcinoma. Gastroenterology. 150:835–853. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang M, Yan H, Li S and Yang J:
Rosmarinic acid protects rat hippocampal neurons from cerebral
ischemia/reperfusion injury via the Akt/JNK3/caspase-3 signaling
pathway. Brain Res. 1657:9–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Venkatesan RS and Sadiq AM: Effect of
morin-5′-sulfonic acid sodium salt on the expression of apoptosis
related proteins caspase 3, Bax and Bcl 2 due to the mercury
induced oxidative stress in albino rats. Biomed Pharmacother.
85:202–208. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mondal A and Bennett LL: Resveratrol
enhances the efficacy of sorafenib mediated apoptosis in human
breast cancer MCF7 cells through ROS, cell cycle inhibition,
caspase 3 and PARP cleavage. Biomed Pharmacother. 84:1906–1914.
2016. View Article : Google Scholar : PubMed/NCBI
|
